Photo: Kwanchai Lettanpunyaporn at Getty Images
Evidation Health, a San Mateo, California-based health analytics data company, landed $153 million in a Series E funding round led by OMERS Growth Equity and Kaiser Permanente Group Trust. McKesson Ventures and B Capital Group also participated.
This comes less than a year after the company closed its $45 million Series D round.
WHAT IT DOES
Evidation is able to combine real-world patient data...
Google’s $2 billion acquisition of Fitbit last month has been met with concern from privacy advocates worried about how the tech giant will use personal fitness data. This reaction prompted the tech giant to clarify that the acquisition is "about devices, not data."
The deal has brought to light a larger issue that we all seem to gloss over: Every day, millions of people publicly share seemingly...
A new study jointly conducted by digital chronic care management tool Omada and Evidation Health found that patients using Omada’s diabetes management program reduced their A1c level and average of 0.8 over the course of the clinical research.
The study included a total of 195 participants with Type 2 diabetes who had an average baseline A1c of 8.93%. Researchers reported that those participants...
Health data analytics company Evidation Health secured a $45 million Series D raise led by B Capital Group. New backers McKesson Ventures and Section 32 joined the round, as did prior backers Revelation Partners, Rethink Impact and SV Health Investors.
The San Mateo company combines real-life patient data collected through more than 100 different sources, such as Apple Health, Fitbit, Epic and...
This morning real-world behavioral data analysis company Evidation Health announced a research initiative that will analyze behavior and symptom data to develop an early warning algorithm for COVID-19.
Funded by the Biomedical Advanced Research and Development Authority (BARDA) and the Bill and Melinda Gates Foundation, the effort will work with 4YouandMe – a nonprofit that helps individuals...
Evidation Health, a technology company that generates insights from real-world behavioral data collected through devices, has kicked off a new effort to better understand individuals' health behaviors and concerns throughout the COVID-19 pandemic.
Yesterday the company announced that it has recruited 100,258 people living in the U.S. into a longitudinal survey through the Achievement app,...
Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population.
First announced in early 2019, the Heartline Study — which also names Evidation Health as a collaborator — is now enrolling seniors aged 65 years or older who...
Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska.
“Over the past few...
CVS Caremark and health data management company Sharecare last week announced the launch of a digital pharmacy savings card for under-covered individuals. Accessed through an app, the Sharecare Rx program will provide discounts on CVS Caremark network drugs as well as search for lower drug prices. The digital card will be accepted at more than 68,000 in-network pharmacies.
“Whether treating strep...
Evidation Health is teaming up with Tidepool to launch a connected device-powered study of nocturnal hypoglycemic events in people with Type 1 diabetes.
The research is novel in that connected devices — including Dexcom continuous glucose monitors, an Emfit sleep monitor, and a WHOOP activity tracker — will allow researchers to access data about overnight low blood sugar events that previously...
